GVR Report cover U.S. Infections Imaging Market Size, Share & Trends Report

U.S. Infections Imaging Market Size, Share & Trends Analysis Report By Imaging Modality (CT, X-rays, Nuclear Medicine), By Indication (Osteomyelitis, Acute appendicitis, CAD, Colitis), By End-use, By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453373
  • Number of Pages: 0
  • Format: Electronic (PDF)

Market Synopsis

Infections are diagnosed by laboratory tests such as blood tests, urine and stool tests, throat swabs, lumbar puncture, etc. Other techniques include imaging scans and biopsies. Identification of most areas of infection has become quick and easy due to the advent of high-resolution cross-sectional imaging. Molecular imaging in the past was mainly used by labeling leucocytes with radioactive agents to identify infections. With the development of functional nuclear imaging, bacterial and viral metabolism can also be imaged directly for potential identification of early infection. Cross-sectional imaging is used routinely to identify and treat sources of infection in patients with fever, leucocytosis, or unexplained hemodynamic instability. Although ultrasound is preferred for the identification of biliary or hepatic sepsis, computed tomography (CT) has proved to be accurate for the identification and treatment of intra-abdominal fluid collections and abscesses.

Nuclear medicine is an effective tool in imaging as it identifies crucial complementary information, allowing visualization of infectious pathophysiology beyond morphologic imaging. There are numerous research activities conducted using nuclear medicine techniques as detection of metabolic abnormalities is done precisely by these techniques and it preceded morphological changes identified by structural imaging. Nuclear medicine techniques are also showing promising results in the diagnosis of COVID-19 infection. Thus nuclear medicine holds a great growth opportunity as an identification tool in the infection imaging market.

U.S. Infections Imaging Market Segmentation

Segments

Details

By Imaging Modality

  • X-rays
  • Mammography
  • CT scans
  • Nuclear Medicine
  • MRI scans
  • Ultrasound

By Indication

  • Acute Appendicitis
  • Musculoskeletal Infection
  • Cardivascular Inflammation
  • Pneumonia
  • Tuberculosis
  • Endocarditis
  • LVAD Infections
  • Crohn’s Disease
  • Colitis
  • Atherosclerosis
  • Coronary Artery Disease
  • Fever of Unknown Origin
  • Osteomyelitis
  • Skin and Soft Tissue Infection
  • Atheroscierosis

By End-use

  • Hospital
  • Diagnostics Imaging Centers
  • Others

 

 

Market Influencer

The guidelines laid down by the American and European Nuclear Medicine Society, state that fever of unknown origin, sarcoidosis, and vasculitis are among the major clinical indications that benefit from nuclear medicine procedures, specifically from performing positron emission tomography (PET) using 18F fluoro-deoxy-glucose with CT (FDG PET/CT). The cost of using these techniques saved nearly 5000 to 11000 USD per patient for diagnosis of fever of unknown origin.In the last 3 decades, the mortality rate of infective endocarditis has remained steady i.e. ~30%.The use of PET/CT technique is still being studied for the effective diagnosis of endocarditis, however, it is proved to be effective in PV endocarditis identification.The American Society of Nuclear Cardiology recommends performing FDG/PET CTA to detect structural vascular changes and complications caused by vasculitis. Osteomyelitis shows nonspecific symptoms, and physical examination and laboratory results often delay identification. Thus, techniques like unenhanced MRI can be used to identify tissue changes and the involvement of surrounding bones within two days of infection onset. However, nuclear medicine test provides high image sensitivity and enables accurate diagnosis. Hence, it is advent that, nuclear medicine is an effective tool in the diagnosis of numerous infections showing low symptoms and reduced sensitivity to other imaging modalities. Other infections that are studied for effective diagnosis using nuclear medicine and other imaging modalities include, acute appendicitis, musculoskeletal infection, cardiovascular inflammation, pneumonia, tuberculosis, endocarditis, myocarditis, LVAD infections, Crohn’s disease, colitis, atherosclerosis, coronary artery disease, and many others.

The key players operating in the market include GE Healthcare, Curium, Bracco, and Lantheus Medical Imaging, Inc.

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.